MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting

Abstract

Insights

MicroRNA 137 (miR-137) is downregulated in osteosarcoma. Upregulating miR-137 inhibits cancer growth and migration, likely by targeting FXYD6.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Osteosarcoma is a primary bone malignancy with limited treatment options.
  • MicroRNAs play crucial roles in cancer development and progression.
  • The specific role of microRNA 137 (miR-137) in osteosarcoma remains largely unexplored.

Purpose of the Study:

  • To investigate the functional role of miR-137 in regulating osteosarcoma.
  • To elucidate the molecular mechanisms underlying miR-137's action in osteosarcoma.

Main Methods:

  • Quantitative RT-PCR to assess miR-137 expression in osteosarcoma tissues and cell lines.
  • In vitro assays (MTT, transwell) to evaluate proliferation and migration upon miR-137 upregulation.
  • In vivo studies using mouse models to assess tumor growth inhibition.
  • Dual-luciferase reporter assays to confirm direct interaction between miR-137 and FXYD6.

Main Results:

  • miR-137 expression was significantly downregulated in osteosarcoma.
  • Ectopic miR-137 upregulation inhibited osteosarcoma cell proliferation and migration in vitro.
  • miR-137 upregulation suppressed osteosarcoma tumor growth in vivo.
  • FXYD6 was identified as a direct target of miR-137, and its upregulation counteracted miR-137's inhibitory effects.

Conclusions:

  • miR-137 functions as a tumor suppressor in osteosarcoma.
  • The tumor-suppressive role of miR-137 is mediated, at least in part, through the regulation of FXYD6.
  • These findings highlight miR-137 as a potential therapeutic target for osteosarcoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K